Drug · DIN 02570181
DEVATIS TOFACITINIB
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since July 21, 2026.
- Drug Identification Number (DIN)
- 02570181
- Company (DIN owner)
- Devatis Canada Inc.Saint John, New Brunswick, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Tofacitinib L04AF01
- Class
- Human
- Record last updated
- August 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TOFACITINIB (TOFACITINIB CITRATE) | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 21, 2026: NOC 37978Abbreviated New Drug Submission (ANDS)
Other DINs named DEVATIS TOFACITINIB
- DIN 02570173 · Approved